DaVita EPS - Earnings per Share 2010-2025 | DVA
DaVita annual and quarterly earnings per share history from 2010 to 2025. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- DaVita EPS for the quarter ending March 31, 2025 was $2.00, a 24.53% decline year-over-year.
- DaVita EPS for the twelve months ending March 31, 2025 was $10.08, a 14.29% increase year-over-year.
- DaVita 2024 annual EPS was $10.73, a 44.61% increase from 2023.
- DaVita 2023 annual EPS was $7.42, a 26.84% increase from 2022.
- DaVita 2022 annual EPS was $5.85, a 34.27% decline from 2021.
| DaVita Annual EPS |
| 2024 |
$10.73 |
| 2023 |
$7.42 |
| 2022 |
$5.85 |
| 2021 |
$8.90 |
| 2020 |
$6.31 |
| 2019 |
$5.27 |
| 2018 |
$0.92 |
| 2017 |
$3.47 |
| 2016 |
$4.29 |
| 2015 |
$1.25 |
| 2014 |
$3.33 |
| 2013 |
$2.95 |
| 2012 |
$2.74 |
| 2011 |
$2.48 |
| 2010 |
$1.97 |
| 2009 |
$2.03 |
| DaVita Quarterly EPS |
| 2025-03-31 |
$2.00 |
| 2024-12-31 |
$3.08 |
| 2024-09-30 |
$2.50 |
| 2024-06-30 |
$2.50 |
| 2024-03-31 |
$2.65 |
| 2023-12-31 |
$1.64 |
| 2023-09-30 |
$2.62 |
| 2023-06-30 |
$1.91 |
| 2023-03-31 |
$1.25 |
| 2022-12-31 |
$0.81 |
| 2022-09-30 |
$1.13 |
| 2022-06-30 |
$2.30 |
| 2022-03-31 |
$1.61 |
| 2021-12-31 |
$1.81 |
| 2021-09-30 |
$2.36 |
| 2021-06-30 |
$2.64 |
| 2021-03-31 |
$2.09 |
| 2020-12-31 |
$1.52 |
| 2020-09-30 |
$1.28 |
| 2020-06-30 |
$1.62 |
| 2020-03-31 |
$1.89 |
| 2019-12-31 |
$1.78 |
| 2019-09-30 |
$0.95 |
| 2019-06-30 |
$1.64 |
| 2019-03-31 |
$0.90 |
| 2018-12-31 |
$-0.77 |
| 2018-09-30 |
$-0.82 |
| 2018-06-30 |
$1.53 |
| 2018-03-31 |
$0.98 |
| 2017-12-31 |
$1.65 |
| 2017-09-30 |
$-1.12 |
| 2017-06-30 |
$0.65 |
| 2017-03-31 |
$2.29 |
| 2016-12-31 |
$0.80 |
| 2016-09-30 |
$2.76 |
| 2016-06-30 |
$0.26 |
| 2016-03-31 |
$0.47 |
| 2015-12-31 |
$-0.01 |
| 2015-09-30 |
$1.00 |
| 2015-06-30 |
$0.78 |
| 2015-03-31 |
$-0.52 |
| 2014-12-31 |
$0.95 |
| 2014-09-30 |
$0.85 |
| 2014-06-30 |
$0.68 |
| 2014-03-31 |
$0.85 |
| 2013-12-31 |
$0.99 |
| 2013-09-30 |
$0.64 |
| 2013-06-30 |
$1.18 |
| 2013-03-31 |
$0.14 |
| 2012-12-31 |
$0.77 |
| 2012-09-30 |
$0.75 |
| 2012-06-30 |
$0.50 |
| 2012-03-31 |
$0.73 |
| 2011-12-31 |
$0.78 |
| 2011-09-30 |
$0.71 |
| 2011-06-30 |
$0.52 |
| 2011-03-31 |
$0.48 |
| 2010-12-31 |
$0.36 |
| 2010-09-30 |
$0.58 |
| 2010-06-30 |
$0.52 |
| 2010-03-31 |
$0.52 |
| 2009-12-31 |
$0.53 |
| 2009-09-30 |
$0.53 |
| 2009-06-30 |
$0.51 |
| 2009-03-31 |
$0.46 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$10.503B |
$12.816B |
|
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
|
